Surgical robotics specialist Virtual Incision Corp. has raised $18 million in its series B round. The round was co-led by new investor Sinopharm Capital, the private equity fund initiated by China's Sinopharm Group, and existing investor Bluestem Capital, with participation from Prairiegold Venture Partners and others.